The incidence and outcome of myeloid malignancies in 2,112 adult patients in south East-EnglandPHEKOO, Karen J; RICHARDS, Mike A; MØLLER, Henrik et al.Haematologica (Roma). 2006, Vol 91, Num 10, pp 1400-1404, issn 0390-6078, 5 p.Article

The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignanciesHOOGEVEEN, André T; ROSSETTI, Stefano; STOYANOVA, Violeta et al.Oncogene (Basingstoke). 2002, Vol 21, Num 43, pp 6703-6712, issn 0950-9232, 10 p.Article

Mutations of PTPN11 are rare in adult myeloid malignancies. Author's replyLEROY, Hugues; CAVE, Hélène; PHILIPPE, Nathalie et al.Haematologica (Roma). 2005, Vol 90, Num 6, pp 853-854, issn 0390-6078, 2 p.Article

Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Côte d'Or (Burgundy, France)MAYNADIE, Marc; GIRODON, François; CARLI, Paule-Marie et al.Haematologica (Roma). 2011, Vol 96, Num 1, pp 55-61, issn 0390-6078, 7 p.Article

Minimal residual disease diagnostics in myeloid malignancies in the post transplant periodBACHER, U; ZANDER, A. R; HAFERLACH, T et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 3, pp 145-157, issn 0268-3369, 13 p.Article

L3mbtl, the mouse orthologue of the imprinted L3MBTL, displays a complex pattern of alternative splicing and escapes genomic imprintingJUAN LI; BENCH, Anthony J; PILTZ, Sandie et al.Genomics (San Diego, Calif.). 2005, Vol 86, Num 4, pp 489-494, issn 0888-7543, 6 p.Article

Genomic gain at 6p21 : a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemiaLA STARZA, R; AVENTIN, A; DI BONA, E et al.Leukemia. 2006, Vol 20, Num 6, pp 958-964, issn 0887-6924, 7 p.Article

Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: Report of 21 new cases, clinical, cytogenetic and molecular genetic featuresSTEVENS-KROEF, M; POPPE, B; HAGEMEIJER, A et al.Leukemia. 2004, Vol 18, Num 6, pp 1108-1114, issn 0887-6924, 7 p.Article

EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MS12 locus at 17q22DE WEER, An; SPELEMAN, Frank; LIPPERT, Eric et al.Haematologica (Roma). 2008, Vol 93, Num 12, pp 1903-1907, issn 0390-6078, 5 p.Article

Incidence, survival and prevalence of myeloid malignancies in EuropeVISSER, O; TRAMA, A; SCHOUTEN, H. C et al.European journal of cancer (1990). 2012, Vol 48, Num 17, pp 3257-3266, issn 0959-8049, 10 p.Article

Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignanciesCARRAI, A; DE LA RUBIA, J; MARTIN, G et al.Leukemia research. 2003, Vol 27, Num 1, pp 5-12, issn 0145-2126, 8 p.Article

Community-acquired infections and their association with myeloid malignanciesTITMARSH, Glen J; MCMULLIN, Mary Frances; MCSHANE, Charlene M et al.Cancer epidemiology (Print). 2014, Vol 38, Num 1, pp 56-61, issn 1877-7821, 6 p.Article

Antianemic Effect of Once Weekly Regimen of Epoetin Alfa 40,000 Units in Anemic Cancer Patients Receiving ChemotherapyVORAVUD, Narin; SRIURANPONG, Virote; SUWANRUSME, Harit et al.Chot Mai Het Thang Phaet. 2007, Vol 90, Num 6, pp 1082-1088, issn 0125-2208, 7 p.Article

Second hematopoietic stem cell transplantation in myeloid malignanciesARFONS, Lisa M; TOMBLYN, Marcie; ROCHA, Vanderson et al.Current opinion in hematology. 2009, Vol 16, Num 2, pp 112-123, issn 1065-6251, 12 p.Article